Merck to stop phase 3 trial of Keytruda plus Lynparza for lung cancer patients Ruchika Sharma8 Dec 2023 3:19 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that it will stop the Phase 3 KEYLYNK-008 trial evaluating...
Marijuana, cigarette smokers at increased risk of emphysema Dr. Kamal Kant Kohli8 Dec 2023 9:45 AM ISTSmoking marijuana in combination with cigarettes may lead to increased damage of the lung's air sacs, according to research being presented today at...
Best treatment for excessive daytime sleepiness Roshni Dhar8 Dec 2023 9:15 AM ISTThe standard treatment for Obstructive Sleep Apnea (OSA) is a positive airway pressure (PAP) mask that uses compressed air to support lung airways...
In-Utero Exposure to COVID-19 Linked to Neurodevelopmental Impairment in infants Dr Riya Dave8 Dec 2023 8:00 AM ISTNew research sheds light on the potential impact of maternal SARS-CoV-2 infection on infants' neurodevelopment when exposed in utero. A prospective...
Quitting smoking improves survival comparable to never smokers: Study Niveditha Subramani7 Dec 2023 9:15 AM IST Smoking is a dangerous habit not only affecting the one smoking but also people around the person. It is the root cause of cancer, heart...
Lupin bags USFDA nod for Varenicline Tablets for smoking cessation treatment Ruchika Sharma6 Dec 2023 11:30 AM ISTVarenicline Tablets, 0.5 mg and 1 mg are indicated for use as an aid to smoking cessation treatment.
Complications from flu largely preventable with annual flu vaccine Dr. Kamal Kant Kohli5 Dec 2023 11:00 PM ISTDuring National Influenza Vaccination Week (December 4-8, 2023), leading public health organizations are encouraging everyone to get a flu shot if...
Empagliflozin may not exhibit clinical or mortality benefit in COVID-19 patients Jacinthlyn Sylvia5 Dec 2023 10:15 AM ISTThe RECOVERY trial has concluded that empagliflozin, a drug proposed for its anti-inflammatory and metabolic effects, does not provide substantial...
Levofloxacin may reduce risk of developing multidrug-resistant tuberculosis in both children and adults Medha Baranwal5 Dec 2023 9:45 AM ISTFrance: Findings from two phase 3 trials revealed that levofloxacin is safe and lowered the risk of multidrug-resistant (MDR) tuberculosis (60%...
DROOL procedure for refractory sialorrhoea improves pulmonary inflammation and reduces hospitalizations after surgery in kids: JAMA Medha Baranwal5 Dec 2023 9:15 AM ISTUSA: DROOL procedure demonstrated a reduction in hospitalizations and an improvement in inflammation after surgery among patients with impaired...
Maternal COVID-19 Vaccination Lowers risk of infection by omicron varient among infants: JAMA Jacinthlyn Sylvia4 Dec 2023 5:00 PM ISTIn a recent population-based cohort study Orlanda Goh and colleagues unveiled crucial insights into the impact of maternal mRNA vaccination on the...
Benralizumab shows Promising in reducing COPD and asthma Exacerbations Jacinthlyn Sylvia3 Dec 2023 7:45 PM ISTA recent retrospective cohort study published in the Annals of Allergy, Asthma & Immunology unveiled the positive impact of benralizumab on...
